JP2022009463A5 - - Google Patents

Download PDF

Info

Publication number
JP2022009463A5
JP2022009463A5 JP2021173867A JP2021173867A JP2022009463A5 JP 2022009463 A5 JP2022009463 A5 JP 2022009463A5 JP 2021173867 A JP2021173867 A JP 2021173867A JP 2021173867 A JP2021173867 A JP 2021173867A JP 2022009463 A5 JP2022009463 A5 JP 2022009463A5
Authority
JP
Japan
Prior art keywords
composition according
formula
complex
mol
dota
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021173867A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022009463A (ja
JP7321230B2 (ja
Filing date
Publication date
Priority claimed from FR1900432A external-priority patent/FR3091873B1/fr
Application filed filed Critical
Publication of JP2022009463A publication Critical patent/JP2022009463A/ja
Publication of JP2022009463A5 publication Critical patent/JP2022009463A5/ja
Application granted granted Critical
Publication of JP7321230B2 publication Critical patent/JP7321230B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021173867A 2019-01-17 2021-10-25 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス Active JP7321230B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR1900432 2019-01-17
PCT/EP2020/051153 WO2020148436A1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
JP2021541202A JP7071596B2 (ja) 2019-01-17 2020-01-17 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021541202A Division JP7071596B2 (ja) 2019-01-17 2020-01-17 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス

Publications (3)

Publication Number Publication Date
JP2022009463A JP2022009463A (ja) 2022-01-14
JP2022009463A5 true JP2022009463A5 (enExample) 2022-02-28
JP7321230B2 JP7321230B2 (ja) 2023-08-04

Family

ID=67001953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021541202A Active JP7071596B2 (ja) 2019-01-17 2020-01-17 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス
JP2021173867A Active JP7321230B2 (ja) 2019-01-17 2021-10-25 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021541202A Active JP7071596B2 (ja) 2019-01-17 2020-01-17 ジアステレオ異性的に濃縮されたpctaから誘導されたガドリニウム及びキレート配位子の錯体並びに調製及び精製プロセス

Country Status (28)

Country Link
US (3) US11590246B2 (enExample)
EP (2) EP3902800B1 (enExample)
JP (2) JP7071596B2 (enExample)
KR (2) KR102438394B1 (enExample)
CN (3) CN113735854B (enExample)
AR (1) AR117835A1 (enExample)
AU (1) AU2020208794B2 (enExample)
BR (1) BR112021014006B1 (enExample)
CA (1) CA3126268C (enExample)
CL (1) CL2021001868A1 (enExample)
CO (1) CO2021009261A2 (enExample)
DK (2) DK3943493T3 (enExample)
ES (2) ES2930136T3 (enExample)
FI (1) FI3943493T3 (enExample)
FR (1) FR3091873B1 (enExample)
HR (2) HRP20221402T1 (enExample)
HU (2) HUE062554T2 (enExample)
IL (1) IL284884B2 (enExample)
MA (2) MA54626A (enExample)
MX (1) MX2021008651A (enExample)
PH (1) PH12021551725A1 (enExample)
PL (2) PL3902800T3 (enExample)
PT (2) PT3902800T (enExample)
RS (1) RS64334B1 (enExample)
SG (1) SG11202107779SA (enExample)
TW (1) TWI811518B (enExample)
WO (1) WO2020148436A1 (enExample)
ZA (1) ZA202104994B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973934B2 (en) 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
US20230339945A1 (en) * 2020-07-17 2023-10-26 Guerbet Method for preparing a chelating ligand derived from pcta
WO2022072947A1 (en) * 2020-10-02 2022-04-07 Eagle Harbor Technologies, Inc. Ion current droop compensation
CN119698423A (zh) * 2022-09-01 2025-03-25 泰瑞诺科有限公司 新型化合物以及包含其的mri造影剂
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) * 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
CA2909919C (fr) * 2013-04-26 2022-07-12 Guerbet Formulation de produit de contraste et son procede de preparation associe
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
SG11201909240SA (en) * 2017-04-28 2019-11-28 Otsuka Pharma Factory Inc Method for manufacturing diastereomer of citric acid derivative
US10973934B2 (en) * 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Similar Documents

Publication Publication Date Title
KR100947913B1 (ko) 스틸벤 유도체 및 이것을 아밀로이드 플라크의 결합 및영상화에 사용하는 용도
Shetty et al. Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18 F-labeling study
JP3271259B2 (ja) 改良された放射性標識
JP2022159345A5 (enExample)
CN103214501B (zh) 一种金属配合物核酸荧光探针
JPH07113032B2 (ja) ガドリニウム‐dota錯体のリシン塩およびその診断用としての適用
CN102321093A (zh) 一种以罗丹明b为母体的氯代色酮酰腙衍生物及其作为荧光探针的应用
HRP20230678T1 (hr) Kompleks gadolinija i kelirajućeg liganda izvedenog iz dijastereoizomerno obogaćenog pcta i postupak za njegovu pripremu i pročišćavanje
JP2025116040A (ja) 放射性金属錯体の製造方法
CN108299322B (zh) 一种制备钆布醇的方法
RU2003120513A (ru) Литиевые комплексы n-(гидроксиметил-2,3-дигидроксипропио)-1,4,7-трискарбоксиметил-1,4,7,10-те трааза циклододекана, их получение и применение
Nagle et al. Crystal structure of bis (2, 2′-bipyridyl) monochlorocopper (II) tetrafluoroborate. A relook at the structural pathway of the bis (2, 2′-bipyridyl) monochlorocopper (II) cation
Johnson et al. Nitrogen compounds of gallium. I, II
BR112017023820B1 (pt) Uso de pelo menos um composto, método de recuperação de pelo menos uma terra rara e compostos da fórmula específica
Moore et al. The Specific Heats at Low Temperatures of Anhydrous Sulfates of Iron, Magnesium, Manganese, and Potassium.
Petersen et al. Quaternary Ammonium Polyborates1
Gorshkov et al. 99Tc NMR study of complexation of [Tc (CO) 3 (H2O) 3]+ with halide and thiocyanate ions in aqueous solutions
CN107129512A (zh) 一种含硒原子的荧光探针及其制备方法与应用
US8822697B2 (en) Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same
JP7773989B2 (ja) 放射性ジルコニウム錯体の製造方法
Miller et al. Synthesis and lanthanide complex formation constants of N'-benzylethylenediamine-N, N, N'-triacetic acid
Pierrard et al. New synthesis of a high molecular weight ligand derived from dota; thermodynamic stability of the MRI contrast agent formed with gadolinium
US20100324319A1 (en) Tame based chelators and uses thereof
EP4377308B1 (en) Compounds for complexation of rare earth elements and/or s-, p-, d- block metals, their coordination compounds, peptide conjugates, method of their preparation and use thereof
Derick et al. THE SCALE OF INFLUENCE OF SUBSTITUENTS IN PARAFFINE MONOBASIC ACIDS AND THE CORRELATION OF IONIZATION WITH STRUCTURE. III. THE DIVALENT OXYGEN ATOM IN THE ε-POSITION.